… letter doesn't specify that, and the prices paid in Medicaid could be substantial for some single source drugs ultimately. And you know, my final point here would be I think We need to move towards some type of tiered pricing globally where you basically price drugs based on the wealth of nations. and you have different prices for low, middle and high income nations because a country like drugs, Germany with a GDP per capita of 54,000 per person can pay a lot more than Vietnam with a GDP per capita of 4,000. (02:07–02:15)
CLAIM
Asserts the need for tiered drug pricing based on national wealth.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
